Bnp Paribas Arbitrage, Snc »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2024-03-31 $21k 22k 0.94
2023-12-31 $1.5M 1.5M 0.98

More positions owned by Bnp Paribas Arbitrage, Snc

Microsoft Corp Equity (MSFT)
Apple Equity (AAPL)
NVIDIA Corp Equity (NVDA)
Meta Platforms Equity (META)
Amazon.com Equity (AMZN)
Tesla Equity (TSLA)
Broadcom Equity (AVGO)
Alphabet Equity (GOOGL)
Advanced Micro Devices Equity (AMD)
Industrial Select Sector SPDR Fund Fund (XLI)
Exxon Mobil Corp Equity (XOM)
iShares Russell 2000 ETF Fund (IWM)
Visa Equity (V)
JPMorgan Chase & Co Equity (JPM)
Alphabet Equity (GOOG)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ubs Global Asset Management Americas
Readystate Asset Management
Steelhead Partners
Calamos Advisors
Aequim Alternative Investments
Davidson Kempner Capital Management
Wolverine Asset Management
Lazard Asset Management
Zazove Associates
Shenkman Capital Management
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capstone Investment Advisors
Citadel Advisors
MacKay Shields

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1